title: MTHFR C677T/A1298C genotype: a possible risk factor for liver sinusoidal obstruction syndrome.
authors.affiliation: 1] Rappaport-Rambam Center for Translational Genetics, B. Rappaport Institute for Research in the Medical Sciences and Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel [2] Clinical Pharmacology Institute, Haifa, Israel.
authors.forename: E
authors.initials: E
authors.lastname: Efrati
authors.affiliation: 1] Rambam Health Care Campus, Hematology Institute, Haifa, Israel [2] Technion-Israel Institute of Technology, B. Rappaport Faculty of Medicine, Haifa, Israel.
authors.forename: T
authors.initials: T
authors.lastname: Zuckerman
authors.affiliation: Rappaport-Rambam Center for Translational Genetics, B. Rappaport Institute for Research in the Medical Sciences and Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel.
authors.forename: E
authors.initials: E
authors.lastname: Ben-Ami
authors.affiliation: 1] Rappaport-Rambam Center for Translational Genetics, B. Rappaport Institute for Research in the Medical Sciences and Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel [2] Clinical Pharmacology Institute, Haifa, Israel [3] Technion-Israel Institute of Technology, B. Rappaport Faculty of Medicine, Haifa, Israel.
authors.forename: N
authors.initials: N
authors.lastname: Krivoy
mesh_terms: D002066:Busulfan / Q000009:adverse effects; D020022:Genetic Predisposition to Disease / Q000453:epidemiology / Q000235:genetics; D005838:Genotype; D006504:Hepatic Veno-Occlusive Disease / Q000139:chemically induced / Q000453:epidemiology / Q000235:genetics*; D006801:Humans; D042965:Methylenetetrahydrofolate Reductase (NADPH2) / Q000235:genetics*; D019653:Myeloablative Agonists / Q000009:adverse effects; D017354:Point Mutation; D012307:Risk Factors
chemical_list: D019653:Myeloablative Agonists; C573423:MTHFR protein, human; D042965:Methylenetetrahydrofolate Reductase (NADPH2); D002066:Busulfan